The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSeverfield Regulatory News (SFR)

Share Price Information for Severfield (SFR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 67.60
Bid: 67.20
Ask: 68.20
Change: -0.60 (-0.88%)
Spread: 1.00 (1.488%)
Open: 69.80
High: 69.80
Low: 67.60
Prev. Close: 68.20
SFR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

16 Jan 2015 17:24

RNS Number : 4453C
Severfield PLC
16 January 2015
 

 

 

 

 

 

 

TR-1 NOTIFICATION OF MAJOR INTEREST IN SHARES

 

 

1. Identity of the issuer or the underlying issuerof existing shares to which voting rights areattached: ii

SEVERFIELD PLC

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

Yes

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

No

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

No

An event changing the breakdown of voting rights

No

Other (please specify):

 

NA

3. Full name of person(s) subject to thenotification obligation: iii

River and Mercantile Asset Management LLP

4. Full name of shareholder(s) (if different from 3.):iv

 

5. Date of the transaction and date onwhich the threshold is crossed orreached: v

08/04/2014

6. Date on which issuer notified:

16/01/2015

7. Threshold(s) that is/are crossed orreached: vi, vii

5%

      
 

 

8. Notified details:

A: Voting rights attached to shares viii, ix

Class/type ofshares

if possible usingthe ISIN CODE

Situation previousto the triggeringtransaction

Resulting situation after the triggering transaction

NumberofShares

NumberofVotingRights

Numberof shares

Number of votingrights

% of voting rights x

Direct

Direct xi

Indirect xii

Direct

Indirect

GB00B27YGJ97

11,748,000

 

3.94%

15,048,000

 

15,048,000

 

NA

5.06%

NA

 

 

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financialinstrument

Expirationdate xiii

Exercise/Conversion Period xiv

Number of votingrights that may beacquired if theinstrument isexercised/ converted.

% of votingrights

 

 

 

 

 

 

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Resulting situation after the triggering transaction

Type of financialinstrument

Exercise price

Expiration date xvii

Exercise/Conversion period xviii

Number of voting rights instrument refers to

 

% of voting rights xix, xx

 

 

 

 

 

 

 

Nominal

Delta

 

 

 

Total (A+B+C)

Number of voting rights

Percentage of voting rights

15,048,000

 

5.06%

                 
 

 

9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: xxi

 

 

 

Proxy Voting:

10. Name of the proxy holder:

River and Mercantile Asset Management LLP

11. Number of voting rights proxy holder will ceaseto hold:

NA

12. Date on which proxy holder will cease to holdvoting rights:

NA

 

13. Additional information:

 

14. Contact name:

Hamish Byrne

15. Contact telephone number:

+44 (0) 20 7601 6262

   

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLDQLFFEFFLBBX
Date   Source Headline
26th Apr 20247:00 amRNSTransaction in Own Shares
25th Apr 20247:14 amRNSTransaction in Own Shares
17th Apr 20247:00 amRNSChairman appointment
17th Apr 20247:00 amRNSTrading Statement
15th Apr 20247:53 amRNSProgressive publish new research
21st Mar 20245:35 pmRNSPDMR Shareholding
19th Feb 20241:58 pmRNSStandard form for notification of major holdings
8th Feb 20247:00 amRNSCDP ‘A List’ for climate change
18th Dec 20231:43 pmRNSDirector/PDMR Shareholding
21st Nov 20238:02 amRNSProgressive publishes new research
21st Nov 20237:00 amRNSInterim Results
6th Nov 20237:00 amRNSNotice of Investor Presentation
9th Oct 20232:46 pmRNSNotification of Transactions of Directors
18th Sep 20234:08 pmRNSRSP grant
6th Sep 20238:54 amRNSProgressive publishes new research
6th Sep 20237:00 amRNSAGM trading update
7th Aug 202312:12 pmRNSNotice of Annual General Meeting and Annual Report
31st Jul 20233:18 pmRNSDirector/PDMR Shareholding
31st Jul 20231:18 pmRNSDirectorate Change
26th Jul 20237:00 amRNSDirectorate Change
14th Jun 20237:00 amRNSNotice of Results and Investor Presentation
14th Jun 20237:00 amRNSFinal Results
18th May 202311:13 amRNSTotal Voting Rights
28th Apr 20237:35 amRNSProgressive publishes Spotlight note
3rd Apr 20232:11 pmRNSCompletion of Acquisition
27th Mar 20237:00 amRNSTrading Statement
21st Mar 202311:03 amRNSNotification of Major Holdings
16th Mar 202312:18 pmRNSProgressive publishes new research
15th Mar 20237:00 amRNSAcquisition
24th Jan 20234:40 pmRNSSecond Price Monitoring Extn
24th Jan 20234:35 pmRNSPrice Monitoring Extension
22nd Dec 20224:40 pmRNSSecond Price Monitoring Extn
22nd Dec 20224:35 pmRNSPrice Monitoring Extension
13th Dec 20221:14 pmRNSDirector/PDMR Shareholding
2nd Dec 202210:19 amRNSNOTICE OF CHANGE TO DIRECTOR DETAILS
22nd Nov 20227:30 amRNSProgressive publishes new research
22nd Nov 20227:00 amRNSInterim Results
9th Nov 20224:41 pmRNSSecond Price Monitoring Extn
9th Nov 20224:36 pmRNSPrice Monitoring Extension
26th Oct 20227:39 amRNSProgressive publishes new research
17th Oct 20224:36 pmRNSPrice Monitoring Extension
13th Oct 20228:27 amRNSDirector/PDMR Shareholding
3rd Oct 202210:16 amRNSDirectorate Change - Replacement
3rd Oct 20227:00 amRNSDirectorate Change
22nd Sep 20224:41 pmRNSSecond Price Monitoring Extn
22nd Sep 20224:36 pmRNSPrice Monitoring Extension
21st Sep 20224:35 pmRNSPrice Monitoring Extension
8th Sep 202211:44 amRNSResult of AGM
8th Sep 20227:31 amRNSProgressive publishes new research
8th Sep 20227:00 amRNSTrading Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.